http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104117071-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2013-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104117071-B |
| titleOfInvention | The 3p of microRNA 491 are in antagonism p glycoprotein（MDR1）Application in the tumor drug resistance of mediation |
| abstract | Prepared for antagonism p glycoprotein the invention discloses the 3p of microRNA 491 (3p of miR 491)（MDR1）Purposes and a kind of pharmaceutical composition for treating tumour in the medicine of the tumor drug resistance of mediation.In the present invention, the 3p of microRNA 491 can lower MDR1 protein expressions, particularly, by increasing capacitance it is possible to increase the cytotoxicity of chemotherapeutics. |
| priorityDate | 2013-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.